Subscribe
Type 2 diabetes mellitus is an epidemic with serious and fatal complications. Some predictions estimate that 440 million persons will have this disease by 2030. Current recommendations state that patients with type 2 diabetes who are receiving monotherapy and who have elevated hemoglobin A1c levels between 7.6% and 9.0% should receive a second agent.
A Simple Treatment That Benefits Lupus Patients: Antimalarials
Lifestyle Changes Deserve a 3-Month Trial
Billions of Dollars Are Wasted From Poor Medication-Taking Behaviors
IT Investments Save VA Billions
Jessica Ailani, MD, FAHS, FAAN; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
Asim V. Farooq, MD; Joann Kang, MD; Nita Lee, MD, MPH
Sanjai Rao, MD, DFAPA; Dawn I. Velligan, PhD
Jacob Sands, MD; Beth Sandy, MSN, CRNP, FAPO; Stephanie McDonald, FNP-BC, AOCNP
John F. Brandsema, MD; Abigail N. Schwaede, MD; Samuel J. Mackenzie, MD, PhD
Anil K. Agarwal, MD; Nissreen Elfadawy, MD, MSc, FASN
Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD
Eytan M. Stein, MD; Marina Kremyanskaya, MD, PhD; Hannah Levavi, MD
Deborah Ristvedt, DO; Melissa Tawa, OD, FAAO
Daniel J. DeAngelo, MD, PhD; Claire Roddie, MD, PhD
Rami Komrokji, MD; Maen Hussein, MD